Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge

Dennis M. Bierle, Ravindra Ganesh, Raymund R. Razonable

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge'. Together they form a unique fingerprint.

Medicine & Life Sciences